IP Library › Granted Patent US 12,396,931
Granted Patent B2
US 12,396,931 · App. 18/423,610 · Granted Aug 26, 2025

Compositions having low sulfate containing surfactants

Inventors: Douglas John Hiban (Newtown, CT); Jamie Lynn Miller (North Haven, CT); Tirucherai Varahan Vasudevan (Bethany, CT)
Assignee: Conopco, Inc.
A61K8/0295A61K8/345A61K8/361A61K8/365A61K8/442A61K8/466A61Q5/02A61Q19/10A61K2800/596
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,396,931
App. No.
18/423,610
Granted
Aug 26, 2025
Kind
B2
Abstract

The invention relates to lamellar liquid composition comprising acyl isethionate, methyl acyl taurate, amphoteric and/or zwitterionic surfactant. Unexpectedly, applicants have found that, when ratio of isethionate to taurate is kept at about to 1:1, enhanced lather is achieved. Other criticalities include ratio of amphoteric and/or zwitterionic to anionic surfactant, total amount of surfactant, and pH.

Claims (33)

1. A no sulfate based liquid lamellar composition comprising:

1) 0.1 to 10% by weight of acyl isethionate;

2) 0.1% to 10% by weight of methyl acyl taurate comprising lauroyl methyl taurate, cocoyl methyl taurate or a mixture thereof;

3) 0.1 to 20% by weight structurant comprising caprylic acid, lauric acid, myristic acid or a mixture thereof;

4) a zwitterionic surfactant;

5) 0.0 to 8.0% by weight nonionic surfactant; and

6) 0 to 15% by weight glycerol

wherein the zwitterionic surfactant is present in an amount of 0.1 to 15 wt % and comprises cocamidopropyl betaine, with the provisos that:

i) total surfactant in the composition is less than 20% by weight;

ii) the composition does not simultaneously comprise 0.01% by weight or more nonionic surfactant and 0.1% by weight or more amphoteric surfactant and/or zwitterionic surfactant and does not simultaneously comprise 0.0% by weight amphoteric and/or zwitterionic surfactant and 0.0% by weight nonionic surfactant;

iii) the ratio of methyl acyl taurate to acyl isethionate surfactant is between 1.5:1 to 1:1.5;

iv) the zwitterionic surfactant to anionic surfactant is at a weight ratio from 1:5 to 2:1;

v) the composition has a pH from 5 to 7.4; and

vi) the composition comprises thickener,

the composition further comprising stearic acid, soybean oil, hydrogenated soybean oil, or a mixture thereof.

2. The composition according to claim 1 wherein the composition further comprises oleic acid, isostearic acid, linoleic acid, linolenic acid, ricinoleic acid or a mixture thereof.

3. The composition according to claim 1 wherein the composition comprises from 0.001 to 7% by weight of the nonionic surfactant.

4. The composition according to claim 1 wherein the composition further comprises phenoxyethanol, hydroxyacetophenone, sorbic acid, or a mixture thereof.

5. The composition according to claim 1 wherein the composition further comprises 1,2-octane diol, 1,2-pentane diol, 1,2-hexane diol or a mixture thereof.

6. The composition according to claim 3 wherein the nonionic surfactant is cocoamidopropyl amine oxide.

7. The composition according to claim 1 wherein the structurant is lauric acid making up from 0.5 to 8% by weight of the composition.

8. The composition according to claim 1 wherein the composition comprises from 0.5 to 8% by weight of the acyl isethionate.

9. The composition according to claim 1 wherein the composition comprises from 1 to 6% by weight of lauroyl methyl taurate, cocoyl methyl taurate or a mixture thereof.

10. The composition according to claim 1 wherein the composition comprises from 1 to 10% by weight lauric acid.

11. The composition according to claim 1 wherein the composition comprises from 0.5 to 8% by weight of the zwitterionic surfactant.

12. The composition according to claim 3 wherein the composition comprises from 1 to 6% by weight of the nonionic surfactant.

13. The composition according to claim 1 wherein the composition further comprises an antioxidant.

14. The composition according to claim 1 wherein the composition comprises from 0.02 to 10% by weight glycerol.

15. The composition according to claim 1 wherein the composition further comprises lavender oil, eucalyptus, lemon oil, starflower oil, thyme, peppermint, rose oil, sage, menthol, cineole, eugenol, citral, citronelle, borneol, linalool, geraniol, primrose, camphor, pinene, limonene, vitamin B3, resorcinol, terpineol, thymol or a mixture thereof.

16. The composition according to claim 1 wherein the composition further comprises benzoyl peroxide, zinc salt, tea tree oil, salicylic acid, lactic acid, glycolic acid, citric acid or a mixture thereof.

17. The composition according to claim 1 wherein the composition further comprises ricinoleic acid, shea butter, sunflower oil, sodium hydroxypropyl starch phosphate or a mixture thereof.

18. The composition according to claim 1 wherein the composition further comprises iodopropynyl butylcarbamate.

19. The composition according to claim 1 wherein the composition further comprises ceramide, vitamin B3, or Vitamin B3 and 4-ethyl resorcinol or 4-hexyl resorcinol or a mixture thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2024
From: HIBAN, DOUGLAS JOHN; MILLER, JAMIE LYNN; VASUDEVAN, TIRUCHERAI VARAHAN
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 066869/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2024
From: LIU, HEATHER; EARLY, JAMES; JACOB, KERIN
To: CONOPCO, INC., D/B/A UNILEVER
Reel/Frame 066823/0845 →
Priority Claims (1)
EP 19175537 · May 21, 2019 · regional
Continuity (2)
Continuation 17611700
Related Publication 20240216232A1 · Jul 4, 2024
References Cited (70)
US 3723325A · Parran, Jr. · 1973 [cited by applicant]
US 5415810A · Lee et al. · 1995 [cited by applicant]
US 5817609A · He et al. · 1998 [cited by applicant]
US 5925603A · D'Angelo · 1999 [cited by applicant]
US 6534456B2 · Hayward et al. · 2003 [cited by applicant]
US 6562874B1 · Ilardi et al. · 2003 [cited by applicant]
US 7659235B2 · Tsaur et al. · 2010 [cited by applicant]
US 9187716B2 · Griffin et al. · 2015 [cited by applicant]
US 9636283B2 · Clapp et al. · 2017 [cited by applicant]
US 11090245B2 · Adamy et al. · 2021 [cited by applicant]
US 11904035B2 · Hiban et al. · 2024 [cited by applicant]
US 20020009484A1 · McAtee et al. · 2002 [cited by applicant]
US 20050143269A1 · Wei et al. · 2005 [cited by applicant]
US 20070141001A1 · Clapp et al. · 2007 [cited by applicant]
US 20080095733A1 · Griffin et al. · 2008 [cited by applicant]
US 20090062406A1 · Loeffler · 2009 [cited by applicant]
US 20120141389A1 · Cotrell et al. · 2012 [cited by applicant]
US 20140162979A1 · Palla-Venkata · 2014 [cited by examiner]
US 20140349902A1 · Allef et al. · 2014 [cited by applicant]
US 20150157540A1 · Rizk et al. · 2015 [cited by applicant]
US 20150297489A1 · Kleinen et al. · 2015 [cited by applicant]
US 20160095804A1 · Xavier et al. · 2016 [cited by applicant]
US 20170196780A1 · Mizuno et al. · 2017 [cited by applicant]
US 20170304173A1 · Elder et al. · 2017 [cited by applicant]
US 20180071198A1 · Lin · 2018 [cited by examiner]
US 20180318195A1 · Blachechen et al. · 2018 [cited by applicant]
US 20190060200A1 · Adamy et al. · 2019 [cited by applicant]
US 20190247286A1 · Watanabe et al. · 2019 [cited by applicant]
US 20190365623A1 · Botto et al. · 2019 [cited by applicant]
US 20200030208A1 · Meyers et al. · 2020 [cited by applicant]
US 20200170894A1 · Park et al. · 2020 [cited by applicant]
US 20210113443A1 · Borish et al. · 2021 [cited by applicant]
US 20210196604A1 · Rowney et al. · 2021 [cited by applicant]
US 20210290517A1 · Dougherty · 2021 [cited by examiner]
US 20210299020A1 · Cruz et al. · 2021 [cited by applicant]
US 20210401716A1 · Gogineni et al. · 2021 [cited by applicant]
US 20220395444A1 · Hutton, III · 2022 [cited by applicant]
US 20230089228A1 · Deng et al. · 2023 [cited by applicant]
US 20230113844A1 · Cochran et al. · 2023 [cited by applicant]
US 20230114446A1 · Cochran et al. · 2023 [cited by applicant]
CN 1897909 · 2007 [cited by applicant]
CN 101330895 · 2008 [cited by applicant]
CN 101375826 · 2009 [cited by applicant]
CN 113811284 · 2021 [cited by applicant]
CN 108697608 · 2022 [cited by applicant]
JP H06001997 · 1994 [cited by applicant]
JP 11513053 · 1999 [cited by applicant]
JP 2002179552 · 2002 [cited by applicant]
JP 2003527409 · 2003 [cited by applicant]
JP 2009057383 · 2009 [cited by applicant]
JP 2010513621 · 2010 [cited by applicant]
WO WO9705857 · 1997 [cited by applicant]
WO WO2014201541 · 2014 [cited by applicant]
WO WO2015089259 · 2015 [cited by applicant]
WO WO2017140799 · 2017 [cited by applicant]
WO WO2019000407 · 2019 [cited by applicant]
WO WO2019011521 · 2019 [cited by applicant]
WO WO2020043336 · 2020 [cited by applicant]
WO WO2020099036 · 2020 [cited by applicant]
WO WO2020229097 · 2020 [cited by applicant]
ZA 9808057 · 1999 [cited by applicant]
Search Report and Written Opinion in EP19175537; Jul. 12, 2019. [cited by applicant]
Search Report and Written Opinion in EP19175538; Aug. 27, 2019. [cited by applicant]
Search Report & Written Opinion in PCTEP2020062329; Jul. 3, 2020. [cited by applicant]
Search Report & Written Opinion in PCTEP2020062328; Jul. 17, 2020. [cited by applicant]
IPRP2 in PCTEP2020062328; Aug. 13, 2021. [cited by applicant]
IPRP2 in PCTEP2020062329; Aug. 10, 2021. [cited by applicant]
Sun et al.; Solubilization of Sodium Cocoyl Isethionate; Journal of Cosmetic Science; vol. 54; pp. 559-568; 2003. [cited by applicant]
Gough; Formulating High Performance, Sulfate Free Cleansing Products; Innospec; 43 pages; 2015. [cited by applicant]
Clariant; Clariant Surfactants: A versatile portfolio for sulfate free, mild cleansing; Industrial Consumer Specialties, Consumer Care; 59 pages; Jan. 14, 2016. [cited by applicant]